or presumed-new ST-segment elevation ≥1 mm in 2 or more contiguous leads or new left-bundle-bunch block on the index electrocardiogram (ECG) with positive cardiac biochemical markers. The diagnosis of NSTEMI was made when positive cardiac biochemical markers were noted without new ST-segment elevation on the index ECG. The positive threshold for cardiac biochemical markers in the current study was a cardiac troponin I concentration >0.4 ng/ml. Cardiogenic shock was defined as a state of hypoperfusion with systolic blood pressure <80 mmHg, or need of intravenous inotropic agents and/or intra-aortic balloon pump to maintain systolic blood pressure >80 mmHg. Angiographic success of PCI was defined as residual diameter stenosis <20% in the presence of grade 3 Thrombolysis In Myocardial Infarction (TIMI) flow.
Statistical Analysis
Quantitative data are presented as mean value ± SD, and qualitative data as frequencies. Continuous variables were compared using unpaired Student's t-tests or ANOVA. Categorical variables were examined by chi-square test or Fisher's exact test. To identify independent predictors for stroke, univariate and multivariate analyses by logistic regression were conducted. From the univariate analyses, the following variables were entered into the multivariate model: diabetes, history of stroke, peripheral vascular disease, creatinine clearance <60 ml/min, left ventricular ejection fraction ≤30%, absence of glycoprotein (GP) IIb/IIIa inhibitor use before PCI, and exigent use of intra-aortic balloon pump. All probability values are 2-tailed and a value of p<0.05 was considered statistically significant. Statistical analyses were performed with Stat View (Stat View 5.0, Abacus Concepts Inc, Berkley, CA, USA).
Results

Baseline Characteristics
The average age of the study population was 64 years (range: 27-97). Of the 2,281 procedures, 1,021 were PCI for STEMI (44.8%), and 1,260 were for NSTEMI (55.2%). A stroke was observed in 20 of the 2,281 procedures for a total incidence of 0.88%.
Compared to patients without stroke, history of previous cerebrovascular accident (p=0.048) and chronic renal failure on dialysis (p=0.047) were more prevalent in patients with stroke (Table 1 ). The stroke group had a trend for more diabetes mellitus (p=0.05) and a history of peripheral vascular disease (p=0.06). Serum creatinine was higher (p= 0.01) and left ventricular ejection fraction was substantially lower (p<0.0001) in the stroke group. Although STEMI and NSTEMI were similarly distributed in the 2 groups, anterior wall STEMI was more frequent in the stroke group.
Procedure Characteristics
Procedure characteristics were comparable, except that patients with stroke had less use of GP IIb/IIIa inhibitors before PCI (p=0.01) and more frequent unplanned use of intra-aortic balloon pumps (p=0.02) compared to those without stroke (Table 2) . Left heart catheterization and/or left ventriculography were performed at the time of PCI in 60% of patients with stroke, and 67% of patients without stroke (p=0.49). Angiography of the internal mammary artery was performed more frequently in the stroke group, although the trend did not reach statistical significance (15% vs 6%, p=0.1). Activated clotting time was obtained at the end of the procedure in 80% of the patients, and similar between the 2 groups (stroke; 282±80 s, control; 270± 56 s, p=0.45). 
Angiographic Characteristics
Patients with stroke more often underwent PCI to left anterior descending coronary artery, although the trend was not statistically significant (50% vs 34%, p=0.09) ( Table 3 ). Other angiographic parameters were similar between the 2 groups.
Stroke Characteristics
Head CT scanning or MRI was performed in all patients with stroke, and 95% of the strokes were ischemic. Ischemic stroke with hemorrhagic conversion was found in 15%. There was only 1 (5%) primary hemorrhagic stroke. Ischemic stroke most often involved major cerebral arterial territories: middle cerebral artery in 55%, vertebrobasilar artery in 20%, posterior cerebral artery in 20% and carotid artery in 5%. The most common presentation was hemiparesis (45%), with two-thirds being right-sided. Confusion or decreased alertness was seen in 35%, aphasia 20%, hemianopsia 10%, diplopia 5% and vertigo 5%. Transthoracic or transesophageal echocardiography was performed in 15 out of the 20 patients with stroke at a mean interval of 6 days after the procedure. Left ventricular thrombus was detected in 1 of 7 (14%) patients with anterior wall STEMI in the stroke group. Other echocardiographic findings possibly associated with cardiac source of emboli, such as left atrial thrombus, mobile aortic plaque and patent foramen ovale were not identified in any of those patients.
In-Hospital Outcomes
Patients with stroke had a trend toward higher in-hospital mortality (10.0% vs 3.8%, p=0.18). Death occurred only in 2 patients who developed dramatic alteration of neurological status during PCI and succumbed to ischemic stroke with hemorrhagic conversion. During admission, pulmonary edema occurred more frequently in the stroke group (15% vs 2%, p=0.007). Hospital stay was significantly prolonged in patients with stroke (8.4±7.5 vs 3.9±4.6 days, p<0.001). Of 18 patients who survived the hospitalization, 61% had a persistent neurological deficit at the time of hospital discharge. 
Predictors for Stroke
Ejection fraction ≤30% was the only independent predictor for in-hospital stroke (odds ratio (OR) =4.3, p=0.003). Although the trend did not reach the statistical significance, pre-procedure use of GP IIb/IIIa inhibitors tended to be a protective factor (OR =0.3, p=0.057) ( Table 4) .
Comparisons of Stroke in Relation to Time From PCI
Of the 20 strokes, 12 (60%) occurred during or within 24 h after PCI, and additional 8 patients developed stroke after 24 h of PCI during the index hospitalization. Of the 12 patients with strokes occurring during or within 24 h after PCI, 9 (75%) developed symptoms during the procedures. In 3 of the 9 patients, changes in mental status were noted immediately after diagnostic angiography but before PCI. In another 2 patients, changes in neurological status were noted during PCI. In the other 4 patients, stroke was suspected at the end of the procedures.
Clinical characteristics were compared among the control group, patients with stroke occurring during or within 24 h after PCI, and those with stroke that occurred more than 24 h after PCI (Table 5 ). For patients with periprocedural stroke (during or within 24 h after PCI), use of GP IIb/IIIa inhibitors before PCI was less frequent (p=0.015), and PCI of a saphenous vein graft was more frequent (p=0.04) than patients without stroke. More patients in the periprocedural stroke group underwent PCI late in the course of MI (more than 24 h after the onset of MI) than patients without stroke (83% vs 48%, p=0.014). Strokes occurring more than 24 h after PCI were more likely to be related to diabetes, cardiogenic shock at presentation, higher serum creatinine, lower ejection fraction, anterior wall STEMI and emergency use of intra-aortic balloon pumps.
Discussion
The present study shows that incidence of stroke in patients undergoing urgent or emergency PCI for NSTEMI or STEMI was 0.88%. Strokes were ischemic in origin in 95% of the cases. The only independent predictor for stroke was low ejection fraction. Sixty percent of the strokes occurred or were noticed during or within 24 h after PCI. These periprocedural strokes were associated with PCI of a saphenous vein graft, absence of GP IIb/IIIa inhibitors use before PCI and late presentation in the course of MI. However, stroke found more than 24 h after PCI were related to diabetes, anterior wall STEMI and compromised hemodynamic state.
Incidence of Stroke Complicating PCI
Stroke is a rare but devastating complication of PCI. Despite of the improvement in techniques and devices, the rate of stroke has increased over the decades. [1] [2] [3] [4] [5] [6] [7] [8] In the late 1970 s to early 1980 s, the incidence of stroke was in the range of 0.03 to 0.06%. 1, 2 From the early 1990 s to recent years, the rate has been 0.12 to 0.3%. [3] [4] [5] [6] [7] [8] A possible explanation for the increased incidence is using PCI for higher-risk patients. The incidence of stroke in the present study was higher than previous reports, which is probably because of different patient characteristics. Emergency or urgent PCI are shown to be associated with higher risk of stroke. 6, 7 Whereas most previous studies have examined the incidence of stroke in stable patients undergoing elective PCI, our population consisted of patients with MI requiring emergency or urgent PCI. Another possible explanation would be the various definitions of stroke. Some studies investigated only stroke occurring within 24 h of the procedure, but our study included all stroke during hospitalization.
Risk Factors for Stroke Complicating PCI
With regard to the predictors for stroke complicating PCI, Fuchs et al showed that use of an intra-aortic balloon pump, advanced age and vein graft intervention were independent predictors for stroke occurring within 24 h of PCI. 6 Dukkipati el al showed that independent predictors for TIA and stroke were diabetes, hypertension, previous cerebrovascular events, creatinine clearance ≤40 ml/min, urgent or emergency procedures, use of thrombolytics or heparin before PCI and exigent use of intra-aortic balloon pumps. 7 Furthermore, Wong et al revealed age, GP IIb/IIIa inhibitor use, acute MI, congestive heart failure on admission, history of carotid disease and chronic renal disease, as independent predictors. 8 However, the majority of patients in those studies underwent elective PCI with limited use of stent and GP IIb/IIIa inhibitors. As for the ACS population with or without PCI, the GRACE registry has shown that the incidence of in-hospital stroke was significantly higher in patients with STEMI than NSTEMI or unstable angina (1.3%, 0.9%, 0.5%, respectively). 11, 12 Previous studies have shown that anterior wall STEMI has higher risk of inhospital stroke. 14, 19, 20 Patients with anterior wall STEMI are more likely to have low ejection fraction, 21 and the incidence of left ventricular mural thrombus is higher, 22 which might account for the higher risk of stroke in those populations. The results of our study are generally in line with those previous reports, except for the absence of upstream use of GP IIb/IIIa inhibitors as a risk factor. In Wong and colleagues' study, the use of GP IIb/IIIa inhibitors increased risk of stroke. 8 However, patients with MI in the study were less than 10% of the population.
The cause of PCI-related strokes is mostly embolic in origin. Potential embolic sources are air injection, atherosclerotic plaque of the ascending aorta, thrombi formed on catheters or guide wires, left ventricular mural thrombi, thrombi in the left atrium and paradoxical embolism through a patent foramen ovale. However, the observation that upfront use of GP IIb/IIIa inhibitors tended to be associated with lower risk of periprocedural stroke in the present study suggests that platelet reactivity and vascular inflammation might play a role. Serum inflammatory markers such as Creactive protein, interleukin-6 and soluble CD40 ligand are shown to predict clinical outcomes in patients with ACS, as well as in those with stroke. [23] [24] [25] [26] [27] Use of GP IIb/IIIa inhibitors has been shown to suppress serum concentrations of these markers and contribute to better outcomes in patients with ACS undergoing PCI. 27, 28 A meta-analysis suggested small excess of ischemic strokes in patients treated with lower doses of abciximab, which might be related to insufficient levels of anti-inflammatory and antiplatelet efficacy. 29 In patients with ACS, vascular inflammation is a systemic condition, which might not be confined to coronary arteries, but extended to carotid arteries. 30 Reducing inflammation and platelet reactivity with those agents might lead to a lower thrombus burden in the vasculature, and a lower probability of thrombus formation on PCI devices, which could decrease the risk of stroke related to the procedure.
Stroke in Relation to Time From PCI
In the present study, 60% of the strokes were found during or within 24 h after PCI.
Interestingly, risk factors associated with those periprocedural strokes seemed to be different from those of strokes occurring later. Patients with stroke occurring more than 24 h after PCI tended to have more anterior wall STEMI, and poorer hemodynamic status suggested by higher serum creatinine, lower ejection fraction and more frequent intraaortic balloon pump requirements. However, patients with periprocedural strokes had none of these characteristics. Instead, they were associated with PCI of the vein grafts, no use of GP IIb/IIIa inhibitors and late presentation in the course of MI. The PCI of vein grafts is known to carry the risk of scraping ascending aortic debris during catheter manipulation, or retrograde embolism of the clot from a culprit graft to the brain. In addition to the absence of GP IIb/IIIa inhibitors, the association of the late presentation in the course of MI with periprocedural stroke supports the role of inflammation. Thromboxane formation by platelets has its peak in the time frame between 24 and 36 h from the onset of ACS. 31 The delayed inflammatory response might be associated with the periprocedural strokes in patients presenting late in the course of MI.
Study Limitations
There are several limitations to the current study. First, the sample size was relatively small. A larger cohort would be required to clarify predictors for stroke because of the small event rate and multifactorial nature of the complication. Second, the actual incidence of neurological events after PCI could be even higher because we included only those cases with clinically and radiographically documented strokes. Third, our study consisted of the mixed population of NSTEMI and STEMI. Although both share similar pathophysiologies in the coronary artery, the causes of stroke might be different. Lastly, data on serum inflammatory markers were not available. Information on C-reactive protein and other specific cytokines will be required to further elucidate the role of inflammation in stroke complicating acute PCI.
Conclusions
Stroke complicating PCI remains a vexing challenge, especially in patients undergoing urgent or emergency procedures for acute MI. In addition to the traditional risk factors, absence of upstream use of GP IIb/IIIa inhibitors and late presentation in the course of MI are associated with the risk of periprocedural stroke. Although the cause of stroke during acute PCI is multifactorial, systemic inflammation might play an important role. Vigilance in these factors can lead to earlier diagnosis, treatment and improved outcome of stroke occurring in patients with acute MI undergoing PCI.
